Periscope Equity LLC is pleased to announce the sale of its portfolio company, MicroMass Communications, Inc., to UDG Healthcare plc (LON: UDG), a global provider of commercial, clinical, communications and packaging services to the healthcare industry and constituent of the FTSE 250, for a total consideration of $75.8 million.
Headquartered in Cary, NC, MicroMass is an award-winning healthcare communications agency with unique expertise in changing patient and provider behavior. MicroMass builds custom marketing programs that help patients with chronic conditions, such as cancer or rare diseases to better engage in their own care and help providers generate better outcome in a value-based healthcare environment.
In December 2015, Periscope Equity acquired MicroMass and merged the company with Strategic Pharma Solutions, another portfolio company Periscope had acquired a year earlier. These two companies matched Periscope Equity’s investment criteria, leveraging the firm’s extensive experience in scaling data and technology companies within the healthcare and marketing services sectors.
“Through the merger of MicroMass and SPS, we set out to create one of the largest independent, full-service, multi-channel healthcare marketing and medical communications companies,” said Steve Jarmel, partner, Periscope Equity. “We achieved our goals by forging a collaborative partnership with the company’s talented management team, rapidly growing the business and delivering an excellent return to our investors.”
“We could not have chosen a better partner than Periscope as our investor,” said Alyson Connor, President of MicroMass. “Our close working partnership with the Periscope team was invaluable from the initial merger integration, to the execution of our strategic plan and ultimate sale to UDG. The entire MicroMass team is thrilled to join an industry leader like UDG and continue serving our clients with a broader spectrum of products and services.” About Periscope Equity Periscope Equity LLC is a Chicago-based, lower middle market private equity firm, focused on the buyouts of technology-enabled business services companies with $2 million to $5 million of EBITDA. Periscope specifically targets founder and entrepreneur-owned businesses with unique products, data, technology or service offerings, a history of sustainable profitability and cash generation. In addition to providing liquidity, financial capital and strategic guidance, Periscope seeks to align and work in harmony with proven management teams and to bring strategic, operational, product and acquisition expertise to drive superior investment returns.